Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (294)	5/18/1999 11:36:00 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3559

"Tiha voda brda valja" Croatian's adage said!

To: scaram(o)uche who wrote (294)	5/20/1999 9:38:00 PM
From: Mounir Abouzakhm	Read Replies (2) \| Respond to of 3559

Rick, Believe me, Dr. Schleifer is much better than the one running Hybridon. The fellow de-listed the company from NASDAQ, had 5 to 1 reverse split, and dropped the stock from mid $70's to $1.5. Yet, he had the guts to write "the loss of E. Andrews Grinstead III's services could have a material adverse effect on Hybridon". I could not believe that some body in his right mind would write something that stupid. Seems to me that companies such as REGN and HYBN (and perhaps RIBI and Compumed) are managed by a bunch of professional losers. It does not matter what kind of technology they have, or how many patents are pending, or who is teaming with them, you can bet that their stocks will go no where as long as the present CEOs are in place. It is pity, but the real losers in this game are not the stock holders but the patients and their families who could have experienced a better quality of life. However, because the stupidity or arrogance or lack of vision of very few individuals, these patients are now doomed and have to experience all kinds of pain and agony. by the way Rick, you are a great guy, your posts and web site are really cool.